North America Leukapheresis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

No. of Pages: 118    |    Report Code: TIPRE00025789    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Leukapheresis Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Leukapheresis Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Leukapheresis Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing use of leukapheresis in cancer and autoimmune treatments
  • 5.1.2 Rising prevalence of blood disorders
5.2 Market Opportunities
  • 5.2.1 Growing demand for therapeutic leukapheresis in clinical settings
  • 5.2.2 Expansion of research applications in blood cell therapies
5.3 Future Trends
  • 5.3.1 Advances in leukapheresis devices for higher efficiency
  • 5.3.2 Expansion of leukapheresis in regenerative medicine applications
5.4 Impact of Drivers and Restraints

6. North America Leukapheresis Market Regional Analysis

6.1 North America Leukapheresis Market Overview
6.2 North America Leukapheresis Market Revenue 2019-2028 (US$ Million)
6.3 North America Leukapheresis Market Forecast Analysis

7. North America Leukapheresis Market Analysis – by Product Type

7.1 Leukapheresis Devices
  • 7.1.1 Overview
  • 7.1.2 Leukapheresis Devices: North America Leukapheresis Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Leukapheresis Disposables
  • 7.2.1 Overview
  • 7.2.2 Leukapheresis Disposables: North America Leukapheresis Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Leukapheresis Market Analysis – by Application

8.1 Research Applications
  • 8.1.1 Overview
  • 8.1.2 Research Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Therapeutic Applications
  • 8.2.1 Overview
  • 8.2.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Leukapheresis Market Analysis – by End User

9.1 Blood Component Providers and Blood Centers
  • 9.1.1 Overview
  • 9.1.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Academic and Research Institutes
  • 9.2.1 Overview
  • 9.2.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Pharmaceutical and Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Transfusion Centers
  • 9.4.1 Overview
  • 9.4.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Leukapheresis Market – North America Analysis

10.1 North America
  • 10.1.1 North America Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Leukapheresis Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Leukapheresis Market Breakdown, by Product Type
    • 10.1.1.1.2 US: North America Leukapheresis Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Leukapheresis Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Leukapheresis Market Breakdown, by Product Type
    • 10.1.1.2.2 Canada: North America Leukapheresis Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Leukapheresis Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Leukapheresis Market Breakdown, by Product Type
    • 10.1.1.3.2 Mexico : North America Leukapheresis Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Leukapheresis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Leukapheresis Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Asahi Kasei Corporation
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Haemonetics Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Terumo Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 HemaCare
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Macopharma
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 AllCells
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 STEMEXPRESS
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 BioIVT
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT 
north-america-leukapheresis-market